Patents by Inventor Lesley Nicolson

Lesley Nicolson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6083511
    Abstract: The present invention involves isolated equine herpesvirus-4 (EHV-4) or gH or gC polypeptides and antigenic fragments. Methods of using the polypeptides and the fragments thereof are also presented.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: July 4, 2000
    Assignees: University Court of the University of Glasgow, Equine Virology Research Foundation
    Inventors: David Edward Onions, Lesley Nicolson
  • Patent number: 6025181
    Abstract: An Equine herpesvirus-4 (EHV-4) mutant which does not produce a functional thymidine kinase due to a deletion and/or insertion in the gene encoding thymidine kinase, the deletion and/or insertion made at a position within the thymidine kinase gene such as to not substantially alter expression of the UL24 gene. Recombinant DNA comprising DNA of the EHV-4 mutant, host cells containing the recombinant DNA, and a process for the preparation of the EHV-4 mutant.
    Type: Grant
    Filed: November 7, 1997
    Date of Patent: February 15, 2000
    Assignees: University Court of the University of Glasgow, Equine Virology Research Foundation
    Inventors: David Edward Onions, Lesley Nicolson
  • Patent number: 5674735
    Abstract: The present invention involves isolated nucleic acid molecules encoding the equine herpesvirus-4 (EHV-4) gH or gC polypeptide, the polypeptides so encoded, and antigenic fragments thereof. Vectors and host cells containing these nucleic acid sequences, and uses thereof, are presented.
    Type: Grant
    Filed: November 23, 1994
    Date of Patent: October 7, 1997
    Assignees: University Court of the University of Glasgow, Equine Virology Research Foundation
    Inventors: David Edward Onions, Lesley Nicolson
  • Patent number: 5674499
    Abstract: The present invention relates to an Equine herpesvirus (EHV) vaccine comprising an EHV having an insertion or deletion in the gene 15 of the EHV genome.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: October 7, 1997
    Assignee: Akzo Nobel N.V.
    Inventors: Martha Jacoba Willemse, Paulus Jacobus Antonius Sondermeijer, Lesley Nicolson